• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    BASi Appoints COO

    Nestlé Health Licenses Codexis’ CDX-6114

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Progenics Launches Mfg. Ops in NJ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Progenics Launches Mfg. Ops in NJ

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Haselmeier Acquires Drug Manufacturing License

    Emerald Health, Lonza Enter Large-Scale Mfg. Pact
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour

    Recipharm Facilities Ready for EU Serialization

    Andrew Alliance, Sartorius Launch Research Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Nestlé Health Licenses Codexis’ CDX-6114

    Personalized Medicine: Getting More Out of Clinical Trials

    SK, Arvelle Sign $530M Deal for Antiepileptic Drug

    Charles River to Pay $510M for Citoxlab

    West, Swissfillon Enter Drug Delivery Partnership
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane, Inc.

    Baxter BioPharma Solutions

    Ajinomoto Bio-Pharma Services

    Vetter Pharma International GmbH

    Jubilant HollisterStier Contract Manufacturing & Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Ajinomoto Bio-Pharma Services

    Aphena Pharma Solutions, Inc.

    Vetter Pharma International GmbH

    Jubilant HollisterStier Contract Manufacturing & Services

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves Emergent’s Smallpox Vaccine

    Will manufacture ACAM2000 in newly-acquired cGMP live viral manufacturing facility in Canton, MA

    Related CONTENT
    • Emergent Pays $125M for Sanofi’s Small Pox Biz
    • FDA & OTC Antiseptics
    • Emergent BioSolutions Wins $63M BARDA Contract
    • The Future of Inhaled Medications and Inhalation Technology
    • AAPS Annual Meeting Preview
    12.01.17
    Emergent BioSolutions said that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for the manufacture of ACAM2000, (Smallpox (Vaccinia) Vaccine, Live) in the company’s newly-acquired cGMP live viral manufacturing facility in Canton, MA. ACAM2000 is the only FDA-licensed vaccine for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection.

    “Finalizing and receiving FDA licensure for the tech transfer of ACAM2000 manufacturing at the Canton facility is a significant step forward in support of the U.S. government’s strategy of establishing domestic capabilities to manufacture an FDA-licensed smallpox vaccine,” said Sean Kirk, senior vice president manufacturing operations and CMO business unit head, Emergent BioSolutions. “Emergent is pleased to achieve this milestone, which is the culmination of almost a decade of investment and dedication of our colleagues at the Canton site. Licensure of this facility helps to ensure that ACAM2000 remains the cornerstone of the U.S. government’s smallpox preparedness efforts, while at the same time positions Emergent to meet the demands of international customers.”

    In its acquisition of the ACAM2000 business, Emergent also acquired a live viral fill/finish facility in Rockville, MD that will be responsible for the processing of bulk ACAM2000 into final packaged vaccine vials. Emergent also assumed responsibility for a 10-year contract with the Centers for Disease Control and Prevention (CDC), originally valued at $425 million, to maintain readiness against smallpox. The contract has a remaining value of $160 million for the delivery of ACAM2000 to the Strategic National Stockpile (SNS). With the approval of the Canton facility, Emergent expects to complete all remaining product deliveries under the existing CDC contract in early 2019.
    Related Searches
    • facility
    • CMO
    • cGMP
    • vials
    Suggested For You
    Contracting And Outsourcing Agenda Contracting And Outsourcing Agenda
    FDA Grants Idera Pharmaceuticals Fast Track Designation FDA Grants Idera Pharmaceuticals Fast Track Designation
    CytomX Receives FDA Acceptance of Investigational New Drug Application CytomX Receives FDA Acceptance of Investigational New Drug Application
    Genmab, Janssen Biotech Submit sBLA for Multiple Myeloma Treatment Genmab, Janssen Biotech Submit sBLA for Multiple Myeloma Treatment
    FDA Awards Fast Track Designation to Intra-Cellular Therapies FDA Awards Fast Track Designation to Intra-Cellular Therapies' Schizophrenia Drug
    FDA Approves First Drug to Treat Extremely Rare Enzyme Disorder FDA Approves First Drug to Treat Extremely Rare Enzyme Disorder
    Allergan’s VRAYLAR Further Approved By FDA Allergan’s VRAYLAR Further Approved By FDA
    Radiolabeling is Still Hot Radiolabeling is Still Hot
    UCB Gains Label Extension for New Anti-Epileptic Drug UCB Gains Label Extension for New Anti-Epileptic Drug
    AAPS Annual Meeting Preview AAPS Annual Meeting Preview
    The Future of Inhaled Medications and Inhalation Technology The Future of Inhaled Medications and Inhalation Technology
    Emergent BioSolutions Wins $63M BARDA Contract Emergent BioSolutions Wins $63M BARDA Contract
    FDA & OTC Antiseptics FDA & OTC Antiseptics
    Emergent Pays $125M for Sanofi’s Small Pox Biz Emergent Pays $125M for Sanofi’s Small Pox Biz

    Related Breaking News

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      IDRI Selects Amyris to Engineer Vaccine Adjuvants

      IDRI Selects Amyris to Engineer Vaccine Adjuvants

      Aims to discover sustainable alternatives to shark squalene to use as vaccine adjuvants
      02.12.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      EMD Serono Expands Bio R&D Facility

      EMD Serono Expands Bio R&D Facility

      Will invest $70 million to expand Billerica, MA facility with a new 145,000 sq.-ft. building
      02.06.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Enzene, Novasep Enter Continuous Mfg. Tie-up

      Enzene, Novasep Enter Continuous Mfg. Tie-up

      Enzene chooses Novasep BioSC Pilot Chromatography for automated continuous manufacture of mAb
      02.05.19


    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      QPS Expands Translational Medicine Division

      QPS Expands Translational Medicine Division

      Triples footprint of its Translational Medicine site in Newark, DE
      02.04.19

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Thermo Fisher, Torque Build Dedicated Slipstream Mfg. Facility

      Thermo Fisher, Torque Build Dedicated Slipstream Mfg. Facility

      Will be used for high-efficiency production of Torque's Deep-Primed T cell immunotherapies
      02.04.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      MabPlex to Expand CDMO Services

      MabPlex to Expand CDMO Services

      Biologics CDMO secures $59.1 Million series A financing round
      01.30.19


    • Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      SGS Expands Glasgow Testing Capabilities

      SGS Expands Glasgow Testing Capabilities

      Invests £7.6 million to expand capabilities and capacity for testing biologics
      01.29.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      EirGenix Opens Mfg. Plant in Taiwan

      EirGenix Opens Mfg. Plant in Taiwan

      Also inks ADC deal with Oncomatryx Biopharma
      01.28.19

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      Orgenesis Plans U.S. Expansion of Masthercell Subsidiary

      Orgenesis Plans U.S. Expansion of Masthercell Subsidiary

      Receives $6.6 million milestone payment from Great Point Partners into Masthercell Global
      01.28.19


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Olon SpA Acquires Italian CDMO

      Olon SpA Acquires Italian CDMO

      Buys fellow Italian CDMO Capua Bioservices to expand footprint in field of microbial fermentation
      01.28.19

    • Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Industry News | Methods Development | R&D
      Cognate & Astero Partner for Cell Thawing Technology

      Cognate & Astero Partner for Cell Thawing Technology

      Cognate will serve as a technology reference partner for Astero's AT6 Cell Thawing Platform allowing Cognate's clients to evaluate and control thaw cycles
      01.23.19

    • Bio News | Biologics, Proteins, Vaccines | Industry News
      LabConnect Reveals Global Sample Processing Network

      LabConnect Reveals Global Sample Processing Network

      The new GSPN will offer a comprehensive global solution for sample preparation and processing requirements
      01.22.19

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Reader Showcase
      Sartorius Launches BIOSTAT RM TX Bioreactor

      Sartorius Launches BIOSTAT RM TX Bioreactor

      New wave mixed system developed specifically for closed, automated expansion of cell products
      01.21.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      PBI Launches Biopharma Contract Services Business

      PBI Launches Biopharma Contract Services Business

      Technology platform touted to improve manufacturing for protein therapeutic candidates
      01.18.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Fujifilm Expands Cell Culture Capabilities

      Fujifilm Expands Cell Culture Capabilities

      Launches next gen Apollo X advanced mammalian expression system
      01.10.19

    Breaking News
    • BASi Appoints COO
    • Nestlé Health Licenses Codexis’ CDX-6114
    • SK, Arvelle Sign $530M Deal for Antiepileptic Drug
    • GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers
    • Progenics Launches Mfg. Ops in NJ
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login